// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Does the presentation of orbital cellulitis exhibit seasonality?

I. Ambrose - European Association for Vision and Eye Research (EVER) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Bacterial Skin Infection

N/A

Micropulse diode laser trabeculoplasty‐ subthreshold is the new threshold

S. Ameen - European Association for Vision and Eye Research (EVER) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Hypertension

N/A

On the day cataract operation cancellations: a prospective audit

S. Balendra - European Association for Vision and Eye Research (EVER) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Cataract

N/A

Improved wound resolution for Entropion Surgery using a microscope‐assisted 8.0 vicryl suture technique

S. Balendra - European Association for Vision and Eye Research (EVER) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Scattered light and retinal sensitivity to contrast

J.L. Barbur - European Association for Vision and Eye Research (EVER) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

UK trainee trabeculectomy outcomes incorporating simulated surgery

A. Bhargava - European Association for Vision and Eye Research (EVER) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Glaucoma

N/A

Phaco Cypass

P. Bloom - European Association for Vision and Eye Research (EVER) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Glaucoma

N/A

Post‐hoc comparison of best‐corrected visual acuity improvement in study and untreated fellow eyes with active non‐infectious uveitis of the posterior segment in the SAKURA program

B. Bodaghi - European Association for Vision and Eye Research (EVER) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Uveitis

Rapacan

New and emerging ocular biomarkers

M.F. Cordeiro - European Association for Vision and Eye Research (EVER) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Methadone hydrochloride

A model to quantify retinal ganglion cell loss in patients

M.F. Cordeiro - European Association for Vision and Eye Research (EVER) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Glaucoma

N/A

The 100 000 genomes project and the Western Eye Hospital experience

F. D'Esposito - European Association for Vision and Eye Research (EVER) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Antisense therapy for Fuchs endothelial corneal dystrophy ameliorates TCF4 repeat‐expansion mediated toxicity

A. Davidson - European Association for Vision and Eye Research (EVER) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Fuchs corneal dystrophy

N/A

RGC cell size and susceptibility to loss in rodent glaucoma models

B. Davis - European Association for Vision and Eye Research (EVER) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Glaucoma

carisoprodol

Evaluation of topical curcumin nanoparticles in of rodent glaucoma models

B. Davis - European Association for Vision and Eye Research (EVER) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Hypertension

liposomal curcumin

Neuroprotective activity of curcumin nanocarriers in rodent models of retinal injury

B. Davis - European Association for Vision and Eye Research (EVER) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

liposomal curcumin

New analysis of the Farnsworth D‐15 test

B. Evans - European Association for Vision and Eye Research (EVER) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Activation of the phosphoinositide 3‐kinase pathway promotes axon regeneration of the optic nerve in vivo

R. Evans - European Association for Vision and Eye Research (EVER) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Diagnosis of pattern dystrophy in a case with multiple sclerosis (MS) on fingolimod (Gilenya) treatment and progressive dyschromatopsia

C. Garnavou-Xirou - European Association for Vision and Eye Research (EVER) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Multiple Sclerosis

Fingolimod

Intraoperative OCT: is it of clinical use? – For

O. Georgiadis - European Association for Vision and Eye Research (EVER) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Characterization of retinal structure in CNGB3‐associated achromatopsia

M. Georgiou - European Association for Vision and Eye Research (EVER) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Achromatopsia

N/A

Copyright © 2026. QuantiNova All rights reserved